Search clinical trials for: Antipsychotic

Total 2581 results

Janssen-Cilag International NV

Completed

Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics (PROSIPAL)

Schizophrenia

France, Ukraine, United Kingdom, Germany, Taiwan, Spain, Poland, Bulgaria, Romania, Russian Federation, South Africa, Greece, Israel, Korea, Republic of, Belgium, Estonia, Turkey, Czech Republic, Austria, Hungary, Lithuania, Slovakia and more
Ortho-McNeil Janssen Scientific Affairs, LLC

Terminated

The Paliperidone ER Observational Study of Economic, Functional, and Clinical Outcomes in Patients With Schizophrenia (POST)

Schizophrenia
FORUM Pharmaceuticals Inc

Completed

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia

Central Nervous System Diseases | Schizophrenia | Schizoaffective Disorder

United States
University of Alabama at Birmingham

Recruiting

Trajectories of Treatment Response as Window Into the Heterogeneity of Psychosis: a Longitudinal Multimodal Imaging Study

Psychosis

United States
Duke University
Janssen, LP

Terminated

Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal

Schizophrenia

United States
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal (PsiProsper)

Schizophrenia

Portugal
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Schizophrenia | Bipolar Disorder | Autistic Disorder | Conduct and Other Disruptive Behavior Disorders

United States, Belgium, Germany, Poland, Greece, Netherlands
Beth Israel Deaconess Medical Center
Dartmouth-Hitchcock Medical Center

Active, not recruiting

Treating Schizophrenia by Correcting Abnormal Brain Development

Schizophrenia

United States
US Department of Veterans Affairs

Completed

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Central South University
China Medical University, China; Xiangya Hospital of Central South University; Sun Yat-sen University and other collaborators

Completed

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

Schizophrenia | Metabolic Syndrome

China
Central South University

Recruiting

A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia

Schizophrenia

China
Dartmouth-Hitchcock Medical Center
Harvard Medical School (HMS and HSDM); National Institute on Alcohol Abuse... and other collaborators

Terminated

Alcoholism and Schizophrenia: Effects of Clozapine

Schizophrenia | Schizoaffective Disorder | Substance Abuse | Dual Diagnosis | Alcohol Abuse | Psychotic Disorder

United States
Janssen-Ortho Inc., Canada

Terminated

A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication

Schizophrenia

Canada, United Kingdom, Australia, Ireland
Dr. Martin A. Katzman

Recruiting

Adjunct Treatment With Cariprazine for Adults With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Canada
Organon and Co

Completed

Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238)

Schizophrenia
AbbVie

Completed

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Depression | Mania | Bipolar I Disorder

United States, Bulgaria, Korea, Republic of, Malaysia, Poland, Puerto Rico, Russian Federation, Serbia, Taiwan, Thailand, Ukraine
AbbVie

Completed

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Major Depressive Disorder

United States, Bulgaria, Estonia, Germany, Hungary, Ukraine, United Kingdom
Organon and Co

Completed

Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)

Psychosis
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

Depression, Bipolar

United States, Ukraine, Bulgaria, Canada, Colombia, Russian Federation
H. Lundbeck A/S

Completed

Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia

Schizophrenia

France
University Hospitals Cleveland Medical Center
Case Western Reserve University

Completed

Asenapine in the Treatment of Older Adults With Bipolar Disorder

Bipolar Disorder

United States
Novartis Pharmaceuticals

Completed

Single-dose Iloperidone Pharmacokinetics in Patients With Mild or Moderate Liver Disease, Compared to Healthy Volunteers

Hepatic Impairment

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine for Mania

Bipolar Disorder | Mania

United States, India
Northwestern University
Novartis Pharmaceuticals

Terminated

Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Centre de Recherche de l'Institut Universitaire...

Unknown

Investigator Initiated Study - Asenapine Early Psychosis

Disorders | Schizophrenia and Disorders With Psychotic Features

Canada
Janssen-Ortho Inc., Canada

Completed

A Trial Comparing Risperidone Long-Acting Injection With Oral Antipsychotic in the Treatment of Early Psychosis

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Canada
Supernus Pharmaceuticals, Inc.

Completed

Open-Label, Extension Study to 810P202

Impulsive Aggression Comorbid With ADHD in Children

United States
Maurizio Fava, MD
Novartis Pharmaceuticals

Completed

Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability

Major Depressive Disorder

United States
AbbVie

Recruiting

Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With Schizophrenia

Schizophrenia

Japan, Taiwan
Vanda Pharmaceuticals

Completed

A Study to Evaluate Iloperidone Long-acting Injection (LAI) for the Treatment of Schizophrenia

Schizophrenia

United States
University of Massachusetts, Worcester
Massachusetts General Hospital; University of North Carolina, Chapel Hill; Augusta... and other collaborators

Completed

Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

Schizophrenia | Schizoaffective Disorder | Substance Use Disorders

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Schizophrenia | Major Depressive Disorder | Bipolar 1 Disorder

United States
Gedeon Richter Plc.

Recruiting

Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

Schizophrenia

Mexico, United States, Bulgaria, Colombia, Romania, Russian Federation, Serbia, Ukraine
Sheba Medical Center

Withdrawn

The Effect of Alpha Linolenic Acid (ALA) Supplementation During Pregnancy

Omega 3 Supplements During Pregnancy

Israel
AbbVie

Completed

Cariprazine Pediatric ASD PK Study

Autism Spectrum Disorder

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Bipolar I Disorder

United States, Hungary, Poland, Spain
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder (DriveSaFe2)

Depressive Disorder, Major

Netherlands
Ellen Cristini de Freitas
Citrosuco Company

Completed

Orange Juice Supplementation in Soccer Players

Healthy Athletes

Brazil
Vanda Pharmaceuticals

Recruiting

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

Schizophrenia | Bipolar I Disorder

United States
AbbVie

Terminated

Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia

Schizophrenia

United States, Serbia, Korea, Republic of, Malaysia, Poland, Bulgaria, Ukraine, Puerto Rico, Romania, Taiwan, Thailand
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine for Bipolar I Disorder

Mania | Bipolar I Disorder

United States, Croatia, Romania, Russian Federation, Serbia, Ukraine
University of Aarhus
H. Lundbeck A/S

Completed

Augmenting Clozapine With Sertindole - SERCLOZ

Schizophrenia

Denmark
Sun Pharmaceutical Industries Limited
bioRASI, LLC

Completed

Bio-equivalence Study Between SAPHRIS and Asenapine (ASN)

Schizophrenia | Bipolar Disorder

United States
Forest Laboratories

Completed

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder

Depression | Bipolar Disorder

United States, Bulgaria, Serbia, Ukraine, Croatia, Romania, Puerto Rico, Slovakia
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression

Bipolar Depression

United States
Jayasree Basivireddy

Recruiting

Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients (CARPZ-01)

Cognitive Impairment | Bipolar I Disorder

Canada
Forest Laboratories
Gedeon Richter Ltd.

Completed

A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia

Schizophrenia

United States, India, Romania, Slovakia, Ukraine
University of Zurich
H. Lundbeck A/S; Psychiatric University Hospital, Zurich

Completed

The Effect of Sertindole on Sensory Gating and Cognition in Healthy Volunteers

Healthy

Switzerland
Forest Laboratories

Completed

Study Evaluating RGH-188 in the Treatment of Patients With Schizophrenia

Schizophrenia

United States
Sultan Qaboos University

Not yet recruiting

Effectiveness of Cariprazine Monotherapy for Treatment of Major Depressive Disorder

Depressive Disorder, Major

Search clinical trials for: Antipsychotic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations